Tower Research Capital LLC (TRC)

Position in XBIO — Xenetic Biosciences, Inc.

CIK 1533421 NEW YORK, NY

Position in XBIO

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,025

-$135 QoQ

Shares Held

696

-13.6% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Sep 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,731,131 across 466 Biotechnology names. XBIO ranks #428 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	4,547	$4,218,570
2	BBIO	BridgeBio Pharma, Inc.	38,206	$2,845,582
3	ARWR	Arrowhead Pharmaceuticals, Inc.	34,537	$2,815,110
4	VRTX	Vertex Pharmaceuticals Inc / Ma	4,292	$2,131,964
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,927	$2,108,602
6	AXSM	Axsome Therapeutics, Inc.	6,437	$1,575,584
7	INSM	INSMED Inc	10,927	$1,165,036
8	ROIV	Roivant Sciences Ltd.	32,746	$1,158,880

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,025	696	-13.6%	Shares	Defined	2026-08-11
2026-03-31	$2,160	806	-79.9%	Shares	Defined	2026-05-15
2025-12-31	$8,706	4,012	+479.8%	Shares	Defined	2026-02-17
2024-09-30	$2,989	692	-25.2%	Shares	Other	2024-11-14
2024-03-31	$3,487	925	-9.3%	Shares	Defined	2024-05-15
2023-12-31	$3,519	1,020	-26.3%	Shares	Defined	2024-02-13
2023-09-30	$6,781	1,384	+122.9%	Shares	Defined	2023-11-14
2023-06-30	$2,036	621	-94.5%	Shares	Defined	2023-08-14
2023-03-31	$4,609	11,354	0.0%	Shares	Defined	2023-05-09
2022-12-31	$3,235	11,354	-2.9%	Shares	Defined	2023-02-10
2022-09-30	$6,277	11,690	-18.7%	Shares	Defined	2022-11-10
2022-06-30	$11,517	14,379	+697.5%	Shares	Defined	2022-08-15
2022-03-31	$1,839	1,803	+7412.5%	Shares	Defined	2022-05-12
2021-12-31	$30	24	-99.2%	Shares	Other	2022-02-14
2021-09-30	$6,160	3,005	—	Shares	Other	2021-11-15
No filing history on record for this holder in this stock.